Renovaro Provides Update to Definitive Agreement with Predictive Oncology — Neutral
RENB GlobeNewsWire — April 04, 2025LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive Agreement with Predictive Oncology Predictive Oncology, Inc. (NASDAQ: POAI) to initiate the previously announced integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States. Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. (“POI”) dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 (collectively, the “Binding Agreements”).

3 Canadian Marijuana Stocks For Long-Term Investing — Positive
CRON TLRY VFF MarijuanaStocks — April 04, 2025Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who have shares in a cannabis company are down. But that doesn't mean that it will stay that way forever. The overall cannabis industry continues to flourish even though that same success doesn't impact the public sector as it used to.

Weekly Option Windfall: Utilities Buck the Trend in 2025 — Neutral
AEP Zacks Investment Research — April 04, 2025Utilities are one group that tend to hold up better during market corrections.

Middlesex Water's Unit Acquires the Water Assets of TOV for $4.6M — Positive
MSEX Zacks Investment Research — April 04, 2025MSEX's unit acquires water assets of the Town of Ocean View for $4.6 million. This deal will expand its operation in Delaware.

ConocoPhillips Plunges 10.2% in a Day: How Should You Play the Stock? — Negative
COP Zacks Investment Research — April 04, 2025COP's upstream operations, like EOG and CVX, are highly exposed to the volatility in oil and gas prices, considering the very nature of its business model.

EHang States No Impact on Operations from Recent U.S.–China Tariff Actions — Neutral
EH GlobeNewsWire — April 04, 2025GUANGZHOU, China, April 04, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world's leading Urban Air Mobility (“UAM”) technology platform company, stated today that recent tariff developments between China and the United States are not expected to have any material impact on the Company's operations.

4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues — Neutral
COR FMS GILD LMAT Zacks Investment Research — April 04, 2025Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.

SBA Communications (SBAC) Moves 5.3% Higher: Will This Strength Last? — Positive
SBAC Zacks Investment Research — April 04, 2025SBA Communications (SBAC) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO per share estimate revisions for the stock suggests that there could be more strength down the road.

First Financial Bancorp to Announce First Quarter 2025 Financial Results on Thursday, April 24, 2025 — Neutral
FFBC PRNewsWire — April 04, 2025CINCINNATI , April 4, 2025 /PRNewswire/ -- First Financial Bancorp. (Nasdaq: FFBC) announced today that it expects to release first quarter 2025 financial results after the market close on Thursday, April 24, 2025.

Anson Funds Nominates Slate of Highly Qualified Directors for Election at Match Group's 2025 Annual Meeting — Neutral
MTCH PRNewsWire — April 04, 2025Issues Letter to Match Stockholders Outlining Urgent Need for Change to Address Long-Term Underperformance Driven by Poor Oversight, Subpar Corporate Governance, and Misaligned Board Culture TORONTO , April 4, 2025 /PRNewswire/ -- Anson Funds Management LP and Anson Advisors Inc., the co-investment advisers of certain investment funds (collectively, "Anson Funds"), and stockholders of Match Group Inc. (NASDAQ: MTCH) ("Match" or the "Company"), today announced that it has nominated a slate of highly qualified directors - Fumbi Chima, Laura Lee, and Kelley Morrell - for election at the Match 2025 Annual Meeting of Stockholders. Anson Funds also published a letter to …

Scorpio Tankers: Priced Like It's Peaking, Performing Like It's Just Beginning — Positive
STNG Seeking Alpha — April 04, 2025Scorpio Tankers boasts a modern fleet and high profitability, trading at a P/E GAAP (TTM) of less than 3 and a dividend yield over 4%. The company benefits from structural trends like shifting global refining capacity and stable demand for refined petroleum products, despite cyclical market perceptions. Financially robust, Scorpio's net profit margin exceeds 53.7%, and its EV/EBITDA ratio is only 2.93, indicating operational excellence and a lean structure.

JPMorgan hikes global recession odds as Trump imposes sweeping tariffs — Negative
JPM Proactive Investors — April 04, 2025JPMorgan Chase & Co (NYSE:JPM, ETR:CMC) has raised its forecast for the probability of a US and global recession in 2025 to 60%, up from 40%, following the announcement of sweeping tariffs by US president Donald Trump. On Wednesday, Trump introduced a 10% base tariff on almost all US imports, along with increased duties targeting dozens of other countries.

Here's Why Investors Should Retain Wingstop Stock for Now — Positive
WING Zacks Investment Research — April 04, 2025WING focuses on AI-powered kitchen technology to reduce quote times, improve consistency and unlock additional demand. Yet, an uncertain macro environment ails.

European ETFs Witness Record Inflows in Q1: Here Are the Winners — Positive
EPOL EUAD EWG Zacks Investment Research — April 04, 2025European ETFs amassed hefty assets in Q1 2025. Here's why.

Buy this Tech Stock for Safety as AI, Mag 7 Plunge on Tariff Fears — Positive
NFLX Zacks Investment Research — April 04, 2025NFLX's 50% climb over the last year is even more impressive since it wasn't fueled by artificial intelligence hype.

Guaranteed Rate Affinity Appoints Lynne Haney as Vice President of Mortgage Lending — Neutral
HOUS GlobeNewsWire — April 04, 2025CHICAGO, April 04, 2025 (GLOBE NEWSWIRE) -- Guaranteed Rate Affinity, a leading mortgage provider offering unparalleled lending services through its exclusive partnership with Coldwell Banker, has appointed Lynne Haney as Vice President of Mortgage Lending. With more than 35 years of industry experience and a strong track record of community involvement, Haney brings deep expertise and a service-first mindset to the role.

XChange TEC.INC Announces Acquisition of Hong Kong Insurance Brokerage Firm to Expand Market Presence — Neutral
XHG PRNewsWire — April 04, 2025SHANGHAI , April 4, 2025 /PRNewswire/ -- XChange TEC.INC (NASDAQ: XHG) (the "Company"), today announced the acquisition of a Hong Kong-based insurance brokerage firm licensed by the Hong Kong Insurance Authority. This transaction grants the Company direct access to Hong Kong's dynamic insurance market and paves the way for the Company to launch tailored insurance solutions for clients across China and international markets.

Exceeds 700 bitcoin produced, a 13% gain month over month Achieves 42.4 exahash, an increase of 4.2% month over month 11,869 bitcoin held in treasury LAS VEGAS , April 4, 2025 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner® (the "Company"), today released its unaudited bitcoin mining and operations update for the month ending March 31, 2025. "We've remained focused on executing our strategy and have built a strong foundation for scalable growth — including the addition of nearly 2 EH/s in Wyoming in March," said Zach Bradford, CEO and President of CleanSpark.

DREAM FINDERS HOMES WINS THE 2025 BUILDER OF THE YEAR AWARD — Neutral
DFH PRNewsWire — April 04, 2025Strong Acquisitions and Record Revenue Made Dream Finders a Standout Choice NEWPORT BEACH, Calif. , April 4, 2025 /PRNewswire/ -- Zonda's BUILDER announced Dream Finders Homes, Inc. ("Dream Finders" or "DFH") (NYSE: DFH) as the 2025 recipient of the prestigious Builder of the Year award.

Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose — Neutral
SONN GlobeNewsWire — April 04, 2025Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq ® )
